| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 127 | 340 | 1,090 | $70 | $1.4M |
| G0378 | Hospital observation service, per hour | 120 | 130 | 1,270 | $560 | $1.2M |
| 96361 | The provider administers intravenous, or IV, fluids with electrolytes through an already established intravenous route for each additional hour to treat more severe dehydration. | 110 | 210 | 2,850 | $180 | $1.1M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 95 | 180 | 3,200 | $90 | $1M |
| 92507 | The provider treats a patient with communication and hearing difficulties by directly interacting with the patient. He assesses the patient with impairment in his ability to make sounds, along with… | 729 | 750 | 1,800 | $80 | $785.8K |
| 99283 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a low level of medical decision making. | 118 | 1,420 | 90 | $130 | $715.2K |
| 99282 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a straightforward level of medical decision making. | 110 | 450 | 370 | $170 | $674.1K |
| 99284 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making. | 197 | 2,210 | 80 | $130 | $473K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc,… | 187 | 300 | 1,710 | $20 | $458.6K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 176 | 290 | 1,900 | $30 | $390.6K |